stockrowVolitionRX Limited
VNRX Healthcare Medical Devices
VolitionRX Limited’s revenue for fiscal 2025 (year ended December 2025) was $1.7 million, up 40.0% from fiscal 2024.
- Revenue
- −1.97%
- EPS
- +29.2%
- Free cash flow
- +18.6%
- Total debt
- +7.56%
Quarter to June 2026, against a year earlier
Follow VNRX
Alert me
VolitionRX Limited (VNRX) EV/Sales
As of 6 November 2026, VolitionRX Limited (VNRX) trades at a EV/Sales of 4.1×. Over the past ten years it has ranged from 4.0× (October 2026) to 21,629× (January 2015); the current reading is higher than 1% of that period. That is above the Medical Devices industry median of 2.8× and above the Healthcare sector median of 3.6×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 21.5× | (50.80%) |
| FY2024 | 43.6× | (42.98%) |
| FY2023 | 76.5× | (81.36%) |
| FY2022 | 410× | (75.11%) |
| FY2021 | 1,648× | (86.26%) |
| FY2020 | 11,996× | 388.34% |
| FY2019 | 2,456× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 8.4× | (42.53%) |
| Mar 2026 | 14.6× | (32.16%) |
| Dec 2025 | 21.5× | (62.34%) |
| Sep 2025 | 57.0× | (12.58%) |
| 23 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| NVNO enVVeno Medical Corporation compare | −50.8× |
| TNON Tenon Medical, Inc. compare | −0.2× |
| WOK WORK Medical Technology Group LTD compare | n/m |
| BDMD Baird Medical Investment Holdings Limited compare | n/m |
| TBIO Telesis Bio Inc. compare | 0.1× |
| INBS Intelligent Bio Solutions Inc. compare | 0.3× |
| BMRA Biomerica, Inc. compare | 0.6× |
| TRIB Trinity Biotech PLC compare | 3.0× |
| VNRX VolitionRX Limited | 4.1× |
| Medical Devices industry median | 2.8× |
| Healthcare sector median | 3.6× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)